The Magazine for Sleep Professionals
Tuesday, September 1, 2026
A significant number of people in America are walking around with undiagnosed sleep disorders. Recent studies indicate 14.5 percent of adults in the U.S. have difficulty falling asleep, and 17.8 percent had difficulty staying asleep.1 While these alarming statistics highlight the urgent need for sleep disorder testing and treatment nationwide, […]
EnsoData, an innovator in AI healthtech solutions, announced a $20 million Series B financing led by Questa Capital. This new capital will enable EnsoData to accelerate adoption of its AI-powered sleep medicine solutions, improving the sleep care pathway for, in the US alone, an estimated 54 million patients suffering from […]
Nihon Kohden, a global leader in medical device innovation for high-precision patient monitoring and diagnostics, proudly announces the launch of its second-generation Live View Panel Pro™, a specialized virtual health system designed to transform remote neurophysiological assessment and treatment. The upgraded platform combines real-time interactive viewing, integrated two-way intercom and […]
A new study to be presented at the SLEEP 2025 annual meeting found that excessive daytime sleepiness is associated with higher odds of all-cause mortality in middle-aged women but not in younger or older women. Results show that the adjusted odds of all-cause mortality were 16% higher in women between […]
A new study to be presented at the SLEEP 2025 annual meeting found that strong family relationships and high parental engagement are among the aspects of social connectedness that are associated with sufficient sleep duration in pre-teen children. Results show that eating dinner with family and participating in neighborhood activities […]
Today marks a transformative moment in the 35-year history of the American Sleep Apnea Association (ASAA). The organization proudly rebrands as the Wellness, Sleep & Circadian Network (WSCN), a global “KNOWLEDGE HUB” empowering anyone, anywhere to own all 24 hours with practical, science-based tools that improve sleep, circadian health, and overall well-being. […]
ProSomnus Sleep Technologies announces EVO Guided. EVO Guided is a new precision, custom oral device for the treatment of Obstructive Sleep Apnea (“OSA”). FDA cleared, patented and covered by most medical insurances, EVO Guided is the first oral device bioengineered to dilate the oropharynx and the velopharynx for optimal therapeutic […]
Harmony Biosciences Holdings, Inc., today announced a settlement agreement with Lupin Limited, resolving the patent infringement litigation related to Lupin’s Abbreviated New Drug Application (ANDA) for a generic version of WAKIX® (pitolisant hydrochloride). As part of the agreement, litigation in the United States District Court for the District of Delaware will […]
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM has been granted Orphan Drug Designation (ODD) from the U.S. Food & Drug Administration (FDA) for the treatment of Idiopathic Hypersomnia (IH). Specifically, ODD was granted based on the plausible hypothesis that LUMRYZ may […]
Nox Medical, a global leader in sleep diagnostic solutions, is proud to unveil the expanded capabilities of Nox Connect™, a secure, cloud-based platform that now features Artificial Intelligence, web-based scoring and interpretation, and a fully integrated Home Sleep Testing Service. The new platform features will be showcased at the SLEEP […]
